Filing Details
- Accession Number:
- 0001209191-11-022795
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-04-13 17:12:16
- Reporting Period:
- 2011-04-11
- Filing Date:
- 2011-04-13
- Accepted Time:
- 2011-04-13 17:12:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1446847 | Ironwood Pharmaceuticals Inc | IRWD | Pharmaceutical Preparations (2834) | 043404176 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1478244 | G Mark Currie | C/O Ironwood Pharmaceuticals, Inc. 301 Binney Street Cambridge MA 02142 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class B Common Stock | Acquisiton | 2011-04-11 | 600 | $0.60 | 210,600 | No | 4 | M | Direct | |
Class B Common Stock | Disposition | 2011-04-11 | 600 | $15.00 | 210,000 | No | 4 | S | Direct | |
Class B Common Stock | Acquisiton | 2011-04-13 | 24,263 | $0.60 | 234,263 | No | 4 | M | Direct | |
Class B Common Stock | Disposition | 2011-04-13 | 24,263 | $15.00 | 210,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class B Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2011-04-11 | 600 | $0.00 | 600 | $0.60 |
Class B Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2011-04-13 | 24,263 | $0.00 | 24,263 | $0.60 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
59,400 | 2012-09-24 | No | 4 | M | Direct | |
35,137 | 2012-09-24 | No | 4 | M | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Class B Common Stock | Employee Stock Option (Right to Buy) | $3.76 | 2018-01-31 | 120,000 | 120,000 | Direct | |
Class B Common Stock | Employee Stock Option (Right to Buy) | $4.89 | 2019-02-11 | 125,000 | 125,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2018-01-31 | 120,000 | 120,000 | Direct |
2019-02-11 | 125,000 | 125,000 | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. In order to effect the sale, these shares of Class B Common Stock were converted into shares of Class A Common Stock in accordance with the issuer's certificate of incorporation.
- The option vested as to 25% of the shares of Class B Common Stock on the first anniversary of August 22, 2002, and 1/48th of the shares of Class B Common Stock vested each month thereafter for the next 36 months. The option was fully vested as of August 22, 2006.
- The expiration date of the option, as reported in the reporting person's Form 3 filed on February 2, 2010, contained a typographical error. The correct expiration date is January 31, 2018.
- The option vests as to 1.25% of the shares of Class B Common Stock on each monthly anniversary of January 1, 2008 for the first 36 months, and vests as to 4.5833% of the shares of Class B Common Stock on each monthly anniversary thereafter. The option is subject to an early exercise provision and is immediately exercisable.
- The expiration date of the option, as reported in the reporting person's Form 3 filed on February 2, 2010, contained a typographical error. The correct expiration date is February 11, 2019.
- The option vests as to 1.25% of the shares of Class B Common Stock on each monthly anniversary of January 1, 2009 for the first 36 months, and vests as to 4.5833% of the shares of Class B Common Stock on each monthly anniversary thereafter. The option is subject to an early exercise provision and is immediately exercisable.